Beams develops intraoperative detection technologies that use medical radiation to reveal tumor tissue during cancer surgery improving precision, reducing residual disease, and supporting surgeons in securing clear margins.
Our innovation is strengthened by partnerships with leading research institutes, hospitals and deep‑tech organisations committed to advancing intraoperative cancer detection. These collaborators provide scientific insight, clinical feedback and expert guidance that help shape and validate our technology.
We are also backed by national innovation funds, investor networks and deep‑tech sponsors whose support accelerates our research and brings nuclear‑guided precision to operating rooms worldwide. Their funding fuels our growth, clinical trials and the broader adoption of our solutions.
Empowering surgeons with real-time, intraoperative tumor detection. Our advanced systems integrate nuclear medicine and photonics to deliver actionable guidance and improve patient outcomes.
Harnessing PET radiotracers and sensitive detectors, our technology reveals sub-millimetric tumor margins, enabling confident surgical navigation.
Designed for seamless use in the operating room, our tools combine ergonomic form factors with intuitive interfaces for efficient workflows.
Instant detection and visualization of residual tumor tissue support faster decisions and reduce the risk of incomplete resection.
Developed alongside leading clinical teams, our solutions are validated through rigorous research and real-world surgical experience.
Beams develops intraoperative systems that couple beta-radiation detection with surgical tools and workflows. By using established radiotracers already injected for imaging or therapy, our technology turns scintillation signals into intuitive feedback for surgeons – directly at the point of care
Beams’ co-founder and president, Virginie Simon, was recently profiled by Les Deeptech, an initiative of Bpifrance highlighting deeptech leaders. The feature shares Virginie’s inspiring journey and the vision driving Beams as it develops innovative tools to transform intraoperative cancer care.
Read article
As part of the 10th anniversary of the 3DEXPERIENCE Lab acceleration program, Beams was invited to present its technology on BFM Business. This opportunity allowed us to share our mission, our scientific roots, and our approach to improving surgical precision through real-time intraoperative tumor detection.
Read article
In 2023, Beams was selected as a laureate of the i-Lab Innovation Competition, France’s leading national program supporting deeptech startups. This milestone recognizes the scientific maturity of the project and supports the transition from advanced research to pre-industrial medical technologies.
Read article
In 2023, Beams was selected in the Challenges magazine list of the 100 startups to invest in, a benchmark ranking highlighting the most promising French technology ventures. This recognition underscores the relevance of Beams’ scientific approach and its long-term potential in medical and nuclear technologies.
Read article
![<subject>[interface] image of a screenshot of a learning module (for a edtech))</subject>](https://cdn.prod.website-files.com/69300e0fc6ddd4426d68b97d/693196f4c4dd07653499d65f_AnimationTriopCable-ezgif.com-resize.gif)